Breast Lesion Localization Market Key Companies, Business Opportunities, and Industry Analysis Research Report by 2030
Emergen Research Logo
Increasing prevalence of breast cancer is a key factor driving breast lesion localization market revenue growth
VANCOUVER, BRITISH COLUMBIA, CANADA, May 9, 2023 /EINPresswire.com/ -- The Global Breast Lesion Localization Market report reviews historical and current data along with in-depth analysis of market dynamics. The worldwide Breast Lesion Localization market analyses the market environment to predict industry growth for the projected years of 2022–2030. Some of the most crucial parts of this study that shed light on the fiercely competitive climate of the market are the SWOT analysis and Porter's Five Forces Analysis. The research includes a thorough examination of the North American, European, Latin American, Asian Pacific, Middle Eastern, and African markets for keywords. This paper looks at other important characteristics of regional markets in addition to the drivers and restraints of revenue growth, production and consumption patterns, shifting consumer tastes, and strict regulatory standards. Several leading companies are focusing on launching and partnering with other industries for development of breast cancer treatment. For instance, on 10 January 2022, Illumina, Inc. announced a multi-year collaboration with Agendia N.V., a leading global company in precision oncology for breast cancer, to co-develop In Vitro Diagnostic (IVD) tests for oncology testing. Through this collaboration, the company will aim to improve the use of Next-Generation Sequencing (NGS) for decentralized oncology testing and is consistent with Illumina's approach to IVD partnerships in oncology. Agendia is the latest addition to Illumina's portfolio of over 30 IVD partners working on over 40 sequencing-based solutions for cancer prognosis, therapy selection, and other applications.
The global breast lesion localization market size was USD 309.5 Million in 2021 and is expected to register a steady revenue CAGR of 5.5% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of breast cancer and awareness of cancer through different government programs and rising government approvals for treatment of cancer are some of the key factors driving market revenue growth. In addition, technological advancement in medical science is another factor driving revenue growth of the market. According to recent trends reported by National Center for Biotechnology Information, breast cancer is the most prevalent cancer that affects women. According to National Center for Biotechnology Information, up to 2020, there were 2.3 million or 11.7% new breast cancer cases, which is expected to surpass lung cancer as the most common type of cancer globally. Moreover, according to epidemiological studies, number of people suffering with breast cancer worldwide is predicted to reach nearly 2 million by 2030. According to recent trends reported by National Center for Biotechnology Information, Indian women suffer from breast cancer more frequently and at a younger age than Western women.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/1644
Key companies operating in the Breast Lesion Localization market include:
SOMATEX Medical Technologies GmbH, BD, Hologic, Inc. MOLLI Surgical Inc., Intramedical Imaging, LLC., IsoAid, BPB Medica, Laurane Medical LLC., CB Information Services, Inc., and Biomedical Srl
The report further examines the market in the key regions of the world with regard to production and consumption patterns, import/export, supply and demand ratio, revenue generation, market share and size, and presence of prominent players in the regions. The report also covers the expansion plans undertaken by companies in the regions under the regional analysis section.
The report closely studies the growth trajectory of the global Breast Lesion Localization market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
Key Benefits of the Report:
Comprehensive analysis of the competitive scenario and its changing dynamics
Analytical data with detailed SWOT analysis and Porter’s Five Forces analysis
In-depth 8-year analysis of the Global Breast Lesion Localization Market
Critical understanding of the key market segments
Comprehensive analysis of the drivers, restraints, trends, and opportunities
Detailed regional analysis and extensive company profiling
Extensive assessment of current and emerging trends of the market
Some Key Highlights From the Report
The hospitals and clinics segment accounted for largest revenue share in 2021. Majority of patients with breast cancer are treated with surgeries, which are performed in hospitals depending on presence of long-term facilities, trained doctors, beds, and availability of medicines. For instance, a mastectomy is a surgical procedure that removes the entire breast, as well as all breast tissue and, in some cases, other nearby tissues. Some women may have both breasts removed during a double mastectomy. These types of services are driving revenue growth of the hospital segment.
The mammography accounted for a significant revenue share in 2021 due to rising technological advancement and government initiatives for development of breast cancer treatment. 3D mammography can help with easy tumor detection and create nearly 300 images of breast structure. These images are stitched together to form a three-dimensional structure of breast tissue, including any abnormalities or tumors. This allows radiologists to examine breast tissues thoroughly to provide accurate diagnostic results.
The North America market accounted for largest revenue share in 2021 due to increasing number of partnerships and collaborations of leading healthcare companies in this region. For instance, on 29 November 2022, iCAD, Inc., Google Health and mammography Artificial Intelligence (AI) vendor announced a strategic collaboration to integrate Google Health's AI technology into iCAD's portfolio of breast imaging AI solutions and improve breast cancer detection and risk assessment in the short term. Through this collaboration, Google Health will approve the license for its mammography research model. Thus, presence of leading healthcare companies is significantly driving market revenue growth.
To learn more details about the Global Breast Lesion Localization Market report, visit @ https://www.emergenresearch.com/industry-report/breast-lesion-localization-market
The report is an investigative study of the technological developments and product advancements, along with a regional analysis for each product and application offered in the market. The fundamental objective of the report is to give an insight into the workings of the Breast Lesion Localization industry. It provides an accurate and strategic outlook of the market with a thorough assessment of the segments and sub-segments of the market. It provides a panoramic view of the industry to offer a deeper understanding of the global industry.
On the basis of type, the market is segmented into
Type Outlook (Revenue, USD Million; 2019-2030)
Wire guided
Non-wire localization
Radioisotope localization
Magnetic seed localization
Applications Outlook (Revenue, USD Million; 2019-2030)
Breast biopsy
Breast conservation
Mammography
End-Use Outlook (Revenue, USD Million; 2019-2030)
Hospitals and clinics
Ambulatory Surgical Centers (ASCs)
Others
In addition, the analytical data are presented in a well-organized format in the form of charts, tables, graphs, figures, and diagrams in the report. This makes it easier for readers to comprehend the market scenario in a beneficial way. In addition, the report aims to provide a forward-looking perspective and an instructive conclusion to assist the reader in making profitable business decisions. The report concludes with a comprehensive SWOT and Porter's Five Forces analysis of the segments anticipated to dominate the market, regional bifurcation, estimated market size and share, and more.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1644
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.
Latest Published Reports by Emergen Research:
HD Maps for Autonomous Vehicles Market
Orthopedics Diagnostic Devices Market
Semiconductor Lasers Market
PEEK Market
Polyolefin Market
Anti-Money Laundering Software Market
Nano Drones Market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyses consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
